Provided by Tiger Trade Technology Pte. Ltd.

Virtus LifeSci Biotech Clinical Trials ETF

48.61
-0.6395-1.30%
Post-market: 48.42-0.1869-0.38%19:35 EDT
Volume:9K
Turnover:451.66K
Market Cap:46.18M
PE:- -
High:49.12
Open:49.12
Low:48.33
Close:49.25
52wk High:56.18
52wk Low:24.54
Shares:950.00K
Float Shares:950.00K
Volume Ratio:0.49
T/O Rate:0.98%
Dividend:0.66
Dividend Rate:1.35%
ROE:--
ROA:--
PB:1.04
PE(LYR):- -

Loading ...

Company Profile

Company Name:
Virtus LifeSci Biotech Clinical Trials ETF
Exchange:
ARCA
Establishment Date:
2014
Employees:
- -
Office Location:
One Financial Plaza,26th Floor,Hartford,Connecticut,United States
Website:
- -
Zip Code:
06103
Fax:
860-241-1024
Introduction:
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.